Detalhe da pesquisa
1.
Cryopreservation of hematopoietic cells using a pre-constituted, protein-free cryopreservative solution with 5% dimethyl sulfoxide.
Cytotherapy
; 22(11): 613-616, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600975
Mostrar mais
Texto completo
Documentos relacionados
2.
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study.
Transfusion
; 52(10): 2225-33, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22320233
3.
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.
Cytotherapy
; 12(5): 684-91, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20524773
